12 Best Medical Stocks to Buy Now
On September 26, Geoff Meacham, Managing Director of Citi Research, appeared on CNBC’s “Closing Bell Overtime” to talk about President Trump’s plan to impose a 100% tariff on “all any branded...
Boston Scientific Corp (BSX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 7,705,384 | $827,635,383 | +14% | 0.33% |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 7,497,657 | $805,323,340 | -6% | 0.91% |
| 3. | D E Shaw D. E. Shaw | 6,755,151 | $725,570,768 | +76% | 0.51% |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 6,529,918 | $701,378,492 | -4% | 0.5% |
| 5. | Citadel Investment Group Ken Griffin | 5,404,305 | $580,476,400 | -1% | 0.1% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $90.29 | 50 | $4,514.60 | 148,168 | 2024-12-03 | Filing | |
| $41.98 | 25,000 | $1,049,450.00 | 25,000 | 2021-11-15 | Filing | |
| $27.50 | 13 | $357.50 | 32,337 | 2017-09-01 | Filing | |
| $27.80 | 30 | $834.00 | 32,324 | 2017-06-16 | Filing | |
| $25.52 | 29 | $740.08 | 32,294 | 2017-04-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $98.38 | 41,755 | $4,107,844.37 | 178,342 | 2025-10-01 | Filing | |
| $98.91 | 8,245 | $815,482.44 | 220,097 | 2025-10-01 | Filing | |
| $105.85 | 28,170 | $2,981,755.06 | 178,342 | 2025-09-02 | Filing | |
| $104.89 | 21,830 | $2,289,661.38 | 206,512 | 2025-09-02 | Filing | |
| $104.63 | 50,000 | $5,231,670.00 | 178,342 | 2025-08-01 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,515 | $733,690 | 0.15% | |
| 2. | 4,473 | $436,699 | 0.15% | |
| 3. | 50,500 | $4,930 | 0.3% | |
| 4. | 46,385 | $4,528 | 0.33% |
News See All
Piper Sandler Reaffirms its Overweight Rating and $115 Price Target on Boston Scientific Corporation (BSX)
On September 25, 2025, Piper Sandler reaffirmed its Overweight rating and $115 price target on Boston Scientific Corporation (NYSE:BSX), a $145.3 billion medical products company, citing confidence in...
14 Stocks That Will Double in the Next 5 Years
Growth stocks are once again becoming popular among investors seeking long-term profits, as equity market volatility has drastically decreased.
Boston Scientific Corporation (BSX) Expands AI-Enhanced Heart Devices With FARAPULSE Approval
Boston Scientific Corporation (NYSE:BSX) is emerging as a top AI-powered biotech stock by embedding artificial intelligence into its medical device portfolio, particularly in cardiology.
Boston Scientific Corporation (BSX) Rated as a ‘Buy’ at Needham on IVL Market Opportunity
Boston Scientific Corporation (NYSE:BSX) is one of the best beginner stocks to buy, according to analysts.
Top 10 AI-Powered Biotech Stocks to Buy Now
The head biotech analyst at Goldman Sachs, Salveen Richter, made an appearance on CNBC's "Squawk Box" on July 25 to discuss a variety of topics, including the status of the biotech industry and what to...
12 Best Beginner Stocks to Buy According to Analysts
Stronger-than-expected corporate profits and the prospect of the US Federal Reserve cutting interest rates are the catalysts likely to push equity markets higher.
Oppenheimer Touts Boston Scientific Corporation (BSX) as the Best Large-Cap MedTech
Boston Scientific Corporation (NYSE:BSX) is one of the best defensive stocks to buy, according to Steve Cohen.
10 Best Defensive Stocks to Buy According to Steve Cohen
Is it time to rebalance investment portfolios on equity valuations soaring with the S&P 500 powering through the 6,500 level? That’s the big question as uncertainty in the US economy hits hard amid ...
Mizuho Raises Boston Scientific (BSX) Price Target as Robotics and Devices Drive Growth
Boston Scientific Corporation (NYSE:BSX) ranks among the top robotics to buy according to analysts.
Hedge Fund Resource Center Billionaire Hedge Funds
